Ferrous sulfate indication
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest ferrous sulfate is indicated for treating anemia, improving iron status, and delivering long-term medication, though it may cause gastrointestinal side effects and has alternatives like lactoferrin and ferrous bisglycinate chelate.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Indications and Efficacy of Ferrous Sulfate
Treatment of Iron-Deficiency Anemia
Standard Therapy for Anemia
Ferrous sulfate is widely used to treat iron-deficiency anemia, a condition characterized by low hemoglobin levels due to insufficient iron. The standard therapy involves administering ferrous sulfate drops or syrup multiple times daily. However, a study comparing single versus three-times-daily dosing in infants found that both regimens were equally effective in treating anemia, with similar side effects, suggesting that a single-dose regimen could improve adherence.
Gastrointestinal Side Effects
Despite its efficacy, ferrous sulfate is associated with significant gastrointestinal (GI) side effects. A systematic review and meta-analysis of randomized controlled trials (RCTs) revealed that ferrous sulfate significantly increases the risk of GI side effects compared to placebo and intravenous iron. This is a critical consideration for patient compliance and overall treatment success.
Comparison with Other Iron Supplements
Ferrous sulfate has been compared with other iron supplements like lactoferrin and ferrous bisglycinate chelate. Studies indicate that lactoferrin may offer better serum iron parameters and fewer GI side effects. Similarly, ferrous bisglycinate chelate has shown comparable efficacy to ferrous sulfate but with potentially lower GI toxicity.
Special Populations
Children with Autism Spectrum Disorders
In children with autism spectrum disorders and low iron stores, ferrous sulfate was tested for its potential to treat insomnia. Although iron supplementation improved iron status, it did not significantly improve primary sleep outcomes, indicating that while ferrous sulfate can enhance iron levels, its benefits on sleep disturbances in this population are limited.
Cancer Patients
For cancer patients with mild non-chemotherapy-induced iron deficiency anemia, ferrous sulfate remains a common treatment. A study comparing it with ferrous bisglycinate chelate found both to be effective, but ferrous bisglycinate chelate might have lower GI toxicity.
Chronic Kidney Disease (CKD) Patients
In patients with CKD, ferrous sulfate was compared with ferric citrate. Ferric citrate showed a greater increase in transferrin saturation and ferritin levels, suggesting it might be more effective in improving iron parameters in this population.
Safety and Tolerability
Non-Anemic Healthy Adults
A study on non-anemic healthy adults found that ferrous sulfate did not increase risks of malarial infectivity, pathogenic bacterial proliferation, or other adverse effects, indicating its safety in this population.
Kidney Transplant Patients
In kidney transplant patients, ferrous sulfate did not affect the pharmacokinetics of mycophenolic acid, an immunosuppressive drug, suggesting that it can be safely co-administered without reducing the efficacy of the immunosuppressive therapy.
Innovative Delivery Methods
Mucoadhesive Microspheres
To improve the bioavailability and reduce side effects of ferrous sulfate, researchers have developed mucoadhesive microspheres. These microspheres, coated with polymers like hydroxypropylmethyl cellulose and chitosan, enhance intestinal absorption and provide sustained release, potentially offering a more effective and tolerable treatment option for anemia.
Conclusion
Ferrous sulfate is a well-established treatment for iron-deficiency anemia, effective across various populations. However, its use is often limited by significant GI side effects. Alternative iron supplements like lactoferrin and ferrous bisglycinate chelate, as well as innovative delivery methods like mucoadhesive microspheres, show promise in improving efficacy and tolerability. Further research and individualized patient assessment are essential to optimize iron supplementation therapy.
Sources and full results
Most relevant research papers on this topic
